Stock Rating Upgrade
The Value Trend Rating for Voyager Therapeutics Inc (NASDAQ: VYGR) improved in recent days from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our next report.
Recent Price Action
On 6/7/24, Voyager Therapeutics Inc (NASDAQ: VYGR) stock declined slightly by -0.7%, closing at $8.42. However, trading volume in this decline was exceptionally low at 48% of normal. Relative to the market the stock has been strong over the last nine months and has risen 3.4% during the last week.
Current PriceTarget Research Rating
VYGR’s future returns on capital are forecasted to fall short of the cost of capital. Accordingly, the company is expected to be a modest Value Eraser.
Voyager Therapeutics has a current Value Trend Rating of C (Neutral). This VT Rating improved in recent days from D previously. With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Voyager Therapeutics has a poor Appreciation Score of 25 but a good Power Rating of 77, producing the Neutral Value Trend Rating.
Be the first to comment